🚀 RECENT AI SUCCESS

Our AI successfully predicted the gap for $SFIX and executed a BUY strategy, securing a +31.52% net profit.

UPGRADE TO SEE LIVE SIGNALS

$ERAS

Erasca Inc

United StatesUNITED STATES
FREE PREVIEW
AVG HISTORICAL GAP2.71%
MAX GAP RECORD17.48%
PREMIUM
AI ACCURACY RATE
92.4%
Unlock AI Insights 🔓

LAST 10 EARNINGS GAPS (%)

VOLATILITY & BIAS PROFILE

AVG VOLATILITY4.1%
Bullish Gaps
Bearish Gaps
Neutral

Intelligence Brief

Erasca, Inc. is a clinical stage precision oncology company. It focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. It has assembled a wholly owned or controlled RAS/MAPK pathway focused pipeline comprising modality-agnostic programs. The company was founded by Jonathan E. Lim and Kevan Shokat on July 2, 2018 and is headquartered in San Diego, CA. Read full dossier

CURRENT AI SIGNAL
BULLISH STRONG
🔓 REVEAL SIGNAL